Any feedback?
Literature summary for 2.4.1.244 extracted from
- Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells (2007), Mol. Cancer Res., 5, 543-552.
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| expressed in HCT-116 cells | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| colonic cancer cell | enhanced expression in primary colon tumors | Homo sapiens | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| UDP-GalNAc + GlcNAc-beta-(1,3)-GalNAc-alpha-p-nitrophenyl | - |
Homo sapiens | UDP + GalNAc-beta-(1,4)-GlcNAc-beta-(1,3)-GalNAc-alpha-p-nitrophenyl | - |
? |  |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| beta1,4-N-acetylgalactosaminyltransferase III | - |
Homo sapiens |
| beta4GalNAc-T3 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2026.1 (March 2026)
Legal
Curated at
Member of
![DSMZ Digital Diversity]()
![Global Core Biodata Resource]()
![ELIXIR Core Data Resource]()
![German Network for Bioinformatics Infrastructure]()
